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Sickle-cell anaemia (SCA) is a clinically 
heterogeneous autosomal recessive 
monogenic chronic anaemia  
characterized by recurrent episodes of 
severe vaso-occlusion, haemolysis and 
infection. Several genetic and 
environmental modifiers have been 
suggested to modulate the onset and 
course of SCA (1). 
As part of a wider research on the 
development and validation of vaso-
occlusion early predictors in SCA, we have 
studied the association between three 
haemolysis biomarkers and the 
inheritance of genetic variants of eleven 
candidate genes in a series of paediatric 
SCA patients. 
Subjects: 99 paediatric SCA  (SS) patients 
(median current age of 9.9 years) 
followed-up in two general hospitals in 
Greater Lisbon area (median follow-
up/patient of 5.0 years).  
Haemolysis biomarkers: LDH and total 
bilirrubin level and reticulocyte count.  
Candidate gene genotyping:  BCL11A, 
CD36, EDN1, HBA, HBB cluster (including 
HBG),  HBS1L-MYB, ITGA4, HMOX1,  
NOS3, THBS1 and VCAM1. 
Statistical analysis: Association 
studies between candidate genotypes and 
haemolysis biomarkers using T test 
ANOVA parametric tests (LDH, total 
bilirrubin) or Mann-Whitney/Kuskal-Wallis 
non-parametric tests (reticulocyte 
count), all performed with SPSS v20.0 
software, with subsequent correction for 
multiple testing (false discovery rate). 
Although in a large number of tests a 
seemingly significant (i.e., p<0.05) 
association was observed, only the 
following ones were confirmed upon 
correction for the false discovery rate:  
• An elevated LDH was associated to 
haplotype 7 within VCAM1.  
• A lower total bilirrubin was associated  
to the 3.7kb deletion at HBA, 
rs2070744_T allele and haplotypes 3 and 
4 at NOS3 and haplotype 9 within VCAM1  
and rs3783598_G and rs3917024_T  
alleles at VCAM1 promoter.  
• A diminished reticulocyte count was 
associated to the 3.7kb deletion at HBA , 
whereas an elevated count was associated 
to rs1984112_G allele at CD36 (see 
figure).  
Furthermore, at the phenotypic level all 
three haemolysis biomarkers were 
positively associated to left ventricle 
dilation, a common chronic complication 
of SCA.  
On the whole, our findings suggest a complex genetic 
architecture for the haemolytic endophenotype in SCA 
involving multiple pathways, namely control of 
erythrocyte volume and haemoglobinisation, vascular  
cell adhesion, NO synthesis and lipid metabolism.   
Further mechanistic studies are needed to explore these 
avenues leading to a better understanding of the inter- 
and intra-individual clinical variability of SCA. 
0 
20 
40 
Q1 
Q4 
Q1 
Q4 CD36_G 
HBA-alpha3.7 
Allele + 
Allele - 
Q1, Q4: 1st and 4th quartile 
average reticulocyte count 
distribution. 
